Sahyouni Mark Jamal, Acevedo Luis Anthony, Rodriguez Sofia Cristina, Chiles Justin Armond, Pennings Nicholas Joseph
Campbell University School of Osteopathic Medicine, Buies Creek, NC, USA.
Obes Pillars. 2024 Jun 14;11:100115. doi: 10.1016/j.obpill.2024.100115. eCollection 2024 Sep.
This case study portrays an unusual case of treatment-induced neuropathy of diabetes (TIND) in a patient with uncontrolled type 2 diabetes (T2D) who achieved rapid improvement in glucose control primarily with dietary intervention. Initial presentation was 50-year-old white male with a long-standing history of obesity and a family history of T2D with a screening glucose level >500mg/dL by glucometer, HbA1c of 14.9%, and initial weight 213 lbs.
The initial intervention included a low-carbohydrate diet, metformin, and a continuous glucose monitor (CGM). Semaglutide was added after seven days.
His glycemia was within the target range within three weeks. Four weeks after initiation of therapy, he developed TIND symptoms consisting of burning, tightness, and numbness of bilateral feet along with 10/10 pain. At three months, his HbA1c dropped to 6.9% and his weight to 195 lbs. Treatment of his TIND reduced his pain from 10/10 to 2/10.
Whereas TIND is commonly associated with the use of insulin or sulfonylureas, this study adds evidence to the paucity of literature regarding TIND precipitated by dietary intervention.
本病例研究描述了一例在2型糖尿病(T2D)控制不佳的患者中出现的罕见的治疗性糖尿病神经病变(TIND)病例,该患者主要通过饮食干预实现了血糖控制的快速改善。患者为一名50岁的白人男性,有长期肥胖病史和T2D家族史,血糖仪筛查血糖水平>500mg/dL,糖化血红蛋白(HbA1c)为14.9%,初始体重213磅。
初始干预措施包括低碳水化合物饮食、二甲双胍和持续葡萄糖监测(CGM)。七天后加用司美格鲁肽。
三周内其血糖水平处于目标范围内。治疗开始四周后,他出现了TIND症状,包括双侧足部灼痛、紧绷感和麻木感,疼痛程度为10分制的10分。三个月时,他的HbA1c降至6.9%,体重降至195磅。对其TIND的治疗使其疼痛程度从10分制的10分降至2分。
虽然TIND通常与胰岛素或磺脲类药物的使用有关,但本研究为饮食干预引发TIND的文献匮乏增添了证据。